Advances in combination therapy for asthma and COPD

Content: Similarities and differences in the pathophysiology of asthma and COPD / Christian Virchow --
Glucocorticoids : pharmacology and mechanisms / Peter Barnes --
Inhaled corticosteroids? clinical effects in asthma and COPD / Paul O'Byrne --
LABAS : pharmacology, mechanisms and interaction with anti-inflammatory treatments / Gary Anderson --
Long and ultra-long acting beta-2-agonists / Mario Cazzola --
The safety of long-acting beta agonists and the development of combination therapies for asthma and chronic obstructive pulmonary disease / Eugene Bleecker --
Inhaled combination therapy with glucocorticoids and long-acting beta-2-agonists in asthma and COPD, current and future perspectives / Jan Lotvall --
Novel anti-inflammatory treatments for asthma and COPD / Ian Adcock --
Novel biologicals alone and in combination in asthma and allergy / William Busse --
Anti-infective treatments in asthma and COPD / Jonathan D.R. Macintyre & Sebastian L. Johnston --
Long acting muscarinic antagonists in asthma and COPD / Denis O'Donnell --
Phosphodiesterase inhibitors in obstructive lung disease / Jan Lotvall --
Biological therapies in development for COPD / Riccardo Polosa --
Triple therapy?, in the management of chronic obstructive lung disease (COPD). The value of combination treatment with inhaled steroid, long acting anticholinergicbronchodilator and long acting beta 2 agonist bronchodilator in COPD / Ronald Dahl.